Adalimumab (trade name Humira) is a type of drug known as an anti-TNF (anti-tumour necrosis factor). In people with rheumatoid arthritis and some other inflammatory diseases a protein called TNF is overproduced in the body, causing inflammation and damage to the joints. Anti-TNF drugs block the action of TNF and so reduce this inflammation.